Ansys CFO to Present at CITI 2020 Global Technology Conference
PITTSBURGH, Sept. 01, 2020 (GLOBE NEWSWIRE) — ANSYS, Inc. (NASDAQ: ANSS), announced today that Maria Shields, Senior Vice President, CFO […]
Athenex Announces FDA Acceptance for Filing of U.S. NDA for Oral Paclitaxel and Encequidar in Metastatic Breast Cancer with Priority Review
FDA grants Priority Review and sets PDUFA target action date of February 28, 2021FDA indicated that it is not currently […]
Zentalis Pharmaceuticals Appoints Alexis Pinto as Chief Legal Officer
NEW YORK and SAN DIEGO, Sept. 01, 2020 (GLOBE NEWSWIRE) — Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company […]
Plus Therapeutics, Inc. receives FDA Orphan Drug Designation for its Novel Glioblastoma Treatment
AUSTIN, Texas, Sept. 01, 2020 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced that the U.S. Food […]
Orchard Therapeutics Announces Additional Interim Results from Proof-of-Concept Study of OTL-203 for MPS-I
Data on all eight patients demonstrate sustained engraftment and supranormal IDUA enzyme expressionTranslation of metabolic correction to clinical outcomes in […]
MediciNova Announces Development Progress on Intranasal Formulation of SARS-CoV-2 Vaccine for COVID-19
LA JOLLA, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market […]
Mimecast Now Certified in the ServiceNow Store
LEXINGTON, Mass., Sept. 01, 2020 (GLOBE NEWSWIRE) — Mimecast (NASDAQ: MIME) today announced it has received certification of its application […]
Wanda Sports Group Company Limited Reports Second Quarter 2020 Results
BEIJING, Sept. 01, 2020 (GLOBE NEWSWIRE) — Wanda Sports Group Company Limited (the “Company” and, together with its consolidated entities, […]
Encore Capital Group Announces New Global Funding Structure
SAN DIEGO, Sept. 01, 2020 (GLOBE NEWSWIRE) — Encore Capital Group, Inc. (NASDAQ: ECPG), an international specialty finance company, today […]
Iterum Therapeutics Announces Expiration and Preliminary Results of Rights Offering
DUBLIN, Ireland and CHICAGO, Aug. 31, 2020 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical […]
